Anxiety DisordersDepressive DisordersPTSDSubstance Use Disorders (SUD)Palliative & End-of-Life DistressEquity and EthicsMDMA

Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists

In a one-time MDMA-assisted clinical trial and training session with three African American female therapists, participants reported culturally salient themes—strength, safety, connection and managing racialisation—that were personally meaningful and clinically instructive. The authors argue these findings show Western psychedelic-therapy models and facilitator training must incorporate cultural competence, epistemic humility and adjunct approaches (e.g. Functional Analytic Psychotherapy) to improve accessibility and effectiveness for Black communities and other marginalised groups.

Authors

  • Thomas Williams
  • Monnica Williams
  • Sara Reed

Published

Journal of Psychedelic Studies
individual Study

Abstract

Psychedelic medicine is an emerging field of research and practice that examines the psychotherapeutic effects of substances classified as hallucinogens on the human mind, body, and spirit. Current research explores the safety and efficacy of these substances for mental health disorders including anxiety, depression, and posttraumatic stress disorder (PTSD). Although current studies explore psychotherapeutic effects from a biomedical perspective, gaps in awareness around cultural issues in the therapeutic process are prominent. African Americans have been absent from psychedelic research as both participants and researchers, and little attention has been paid to the potential of psychedelics to address traumas caused by racialization. This paper examines cultural themes and clinical applications from the one-time use of 3,4-methylenedioxymethamphetamine (MDMA) as part of an US Food and Drug Administration (FDA)-approved clinical trial and training exercise for three African American female therapists. The primary themes that emerged across the varied experiences centered on strength, safety, connection, and managing oppression/racialization. The participants' experiences were found to be personally meaningful and instructive for how Western models of psychedelic-assisted psychotherapy could be more effective and accessible to the Black community. Included is a discussion of the importance of facilitator training to make best use of emerging material when it includes cultural, racial, and spiritual themes. A lack of knowledge and epistemic humility can create barriers to treatment for underserved populations. Implications for future research and practice for marginalized cultural groups are also discussed, including consideration of Functional Analytic Psychotherapy (FAP) as an adjunct to the psychedelic-therapy approaches currently advanced. As women of color are among the most stigmatized groups of people, it is essential to incorporate their perspectives into the literature to expand conversations about health equity.

Available with Blossom Pro

Research Summary of 'Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists'

Introduction

Psychedelic compounds are re-emerging in Western medicine as possible adjuncts to psychotherapy for disorders such as PTSD, mood disorders, substance use disorders, and end-of-life anxiety. The literature to date is heavily Eurocentric and medicalised, and the authors note a marked absence of people of colour as research participants and as researchers. Little attention has been paid to how psychedelics may interact with racial and cultural trauma, or how existing therapeutic protocols might need adapting to different cultural contexts. This paper reports the written accounts of three African American female clinicians who took part in an FDA‑approved MDMA training exercise (a healthy‑volunteer study linked to MAPS training) and uses an iterative thematic analysis to identify cultural and clinical themes. Williams and colleagues set out to describe what emerged for these therapists during MDMA‑assisted sessions, to consider implications for therapist training and practice, and to suggest clinical approaches (including Functional Analytic Psychotherapy) that might improve cultural responsiveness in psychedelic‑assisted psychotherapy. The work is positioned as a descriptive, practice‑oriented contribution intended to inform culturally sensitive research and clinical practice rather than as an efficacy trial.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (9)

Papers cited by this study that are also in Blossom

Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism

Bogenschutz, M. P., Forcehimes, A. A. · Journal of Humanistic Psychology (2016)

Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes

Brown, T. K., Alper, K. · The American Journal of Drug and Alcohol Abuse (2017)

Psychedelics not linked to mental health problems or suicidal behavior: A population study.

Johansen, P. Ø., Krebs, T. S. · Journal of Psychopharmacology (2015)

Toward a contextual psychedelic-assisted therapy: Perspectives from Acceptance and Commitment Therapy and contextual behavioral science

Luoma, J. B., Sabucedo, P., Eriksson, J. et al. · Journal of Contextual Behavioral Science (2019)

Key interindividual determinants in MDMA pharmacodynamics

Papaseit, E., Torrens, M., Pérez-Mañá, C. et al. · Expert Opinion on Drug Metabolism and Toxicology (2018)

Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame

Sloshower, J., Guss, J., Krause, R. et al. · Journal of Contextual Behavioral Science (2020)

Cited By (7)

Papers in Blossom that reference this study

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression

Murphy, R., Murphy-Beiner, A., Kettner, H. et al. · Frontiers in Pharmacology (2022)

162 cited
The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of its Provision

Smith, D., Faber, S., Buchanan, N. T. et al. · Frontiers in Psychiatry (2022)

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics

Earp, B. D., Repantis, D., Langlitz, N. et al. · Frontiers in Psychiatry (2021)

28 cited
Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions

Mayer, C. E., LeBaron, V. T., Acquaviva, K. D. · Journal of Psychoactive Drugs (2021)

12 cited
Research abuses against people of colour and other vulnerable groups in early psychedelic research

Strauss, D., de la Salle, S., Sloshower, J. A. et al. · Journal of Medical Ethics (2021)

Set and Setting in the Santo Daime

Hartogsohn, I. · Frontiers in Pharmacology (2021)

Ketamine-Assisted Psychotherapy for PTSD Related to Racial Discrimination

Halstead, M., Reed, S., Krause, R. et al. · Clinical Case Studies (2021)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Culture and psychedelic psychotherapy: Ethnic and... — Research Summary & Context | Blossom